Advansix stock holds in the mid teens as fresh filings highlight mixed institutional flows

Published on 08/31/2026 at 18:08 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Advansix stock trades in the mid teens while recent institutional filings show both new buying and share sales, against a backdrop of a reduce consensus rating and a mid $20 price target.

ASIX, US00773T1016, Illustration mit AI erstellt.

Advansix Inc. (ISIN US00773T1016) stock is trading in the mid teens as of August 31, 2026, with several new institutional filings showing both fresh buying and share sales in recent weeks. A consensus view that the shares merit a reduce rating with a price target in the low $20s underscores that the market remains cautious on upside, even as the company continues to execute on its chemical portfolio.

Institutional filings show selling and new positions

A recent filing details that one large institutional holder has sold a portion of its Advansix position, signaling that some investors are taking profits or reallocating capital as the stock consolidates. The same disclosure notes that Advansix opened at $16.53 in the most recent trading session discussed in the filing, framing the current level in the mid teens as consistent with recent market pricing. The move illustrates how institutional activity can adjust around a fairly tight price range even when the broader rating environment is muted.

In contrast, another filing shows that a different institution has initiated a new stake in Advansix, suggesting that not all professional investors are exiting the name at current levels. This second disclosure also references an opening price of $16.53 for the most recently covered session, reinforcing that institutional interest has been active with the shares trading in the same mid teens band. For investors, the combination of one institution selling and another stepping in to buy underscores that views on the stock are divided but that there is still demand for exposure at current prices.

Consensus rating points to limited upside

Market data compiled in the filings indicates that Advansix presently carries a consensus rating of reduce and a consensus price target of $21.50, signaling that analysts and data providers see only modest upside from the current trading range. With the stock in the mid teens, the consensus target implies a potential gain of a bit more than $5 per share if the shares were to move up toward that level, highlighting that expectations for a dramatic re-rating are limited at this stage. For investors, this relatively constrained target suggests that the company may need a stronger earnings or operational catalyst to justify a higher valuation.

At a mid teens share price, Advansix’s implied market capitalization falls in the mid hundreds of millions of dollars as of August 31, 2026, placing the company firmly in the small-cap segment of the chemicals space. A market-data snapshot that groups Advansix alongside larger peers shows the company at a market cap of $445.25 million when the shares trade close to $16.49, giving a concrete sense of its scale compared to global diversified chemicals firms. The combination of a small-cap valuation and a cautious consensus rating reinforces that the market views the stock as more of a niche cyclical play than a core large-cap holding.

Recent trading range and reference levels

Intraday quote information from a recent chart view lists Advansix at $20.09 with a modest gain of 0.15 percent, indicating that the stock has also traded in the low $20s during the period covered by that data. Taken together with the mid teens levels cited in the institutional filings, this suggests that the shares’ recent trading band has spanned from the mid teens up to just above $20.00, with the current price sitting below the consensus target of $21.50. The fact that the shares are trading under the target while having reached $20.09 in prior sessions gives investors a reference point for how the market has reacted to recent news and positioning.

Across these data points, one salient comparison is the relationship between the current mid teens price and the $21.50 consensus target. The gap of several dollars per share shows that while the stock is not dramatically mispriced in the eyes of analysts, there is a defined upside corridor that could be realized if operating performance and sector conditions cooperate. For investors tracking entry and exit points, the prior $20.09 print and the consensus target provide two clear levels that can serve as guideposts when assessing whether the shares are trading rich or cheap relative to expectations.

Core chemicals portfolio as the operating backbone

Advansix’s portfolio centers on key chemical products used in a range of industrial and consumer applications, including nylon intermediates and related chemical inputs for fertilizers and plastics. These products tie the company’s earnings path closely to global demand cycles in agriculture, packaging, and manufacturing, which can translate into periods of higher margins when input costs and selling prices move favorably. For investors, understanding this product mix is critical, because it explains why the shares can be sensitive to commodity price swings and macroeconomic data, even if no single headline dominates the news flow on a given day.

In practice, the chemicals portfolio means that Advansix’s revenue mix and operating income are driven by production volumes, pricing discipline, and the company’s ability to optimize its asset base. When demand for nylon and related chemicals is robust, the firm can leverage fixed assets, boosting margins and cash generation; when conditions soften, management typically focuses on cost containment and disciplined capital allocation to navigate the cycle. These operational levers, combined with the small-cap market capitalization highlighted by recent data snapshots, frame the investment case as a cyclical chemicals story that is influenced as much by sector fundamentals as by company-specific initiatives.

Advansix shares and today’s valuation context

As of August 31, 2026, Advansix shares trade in the mid teens on their primary U.S. listing, aligning with the $16.49 to $16.53 levels cited in recent institutional and market-data disclosures. Against a consensus price target of $21.50 and an observed print of $20.09 in prior sessions, the current price places the stock at a discount to those reference points, while the market cap of $445.25 million underscores its positioning in the small-cap chemicals space. For investors, the mixed institutional flows, cautious consensus rating, and clearly defined corridor between the prevailing price and target levels combine to paint a picture of a stock where the next move is likely to depend on how effectively the company converts its chemicals franchise into stronger earnings and cash flow over the coming quarters.

Institutional filing on share sales in Advansix

Institutional filing on a new Advansix position

Market data snapshot including Advansix